K2 Principal Fund’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

K2 Principal Fund’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-227,992	Closed	-$17.1M	–	275
2015 Q3	$17.1M	Buy	+227,992	New	+$17M	2.77%	8

K2 Principal Fund's KYTH Position: Q4 2015 in Review

K2 Principal Fund sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 227,992 shares — an estimated $17.1M sold.

K2 Principal Fund first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $17.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

K2 Principal Fund reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
K2 Principal Fund sold 227,992 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $17.1M.
K2 Principal Fund first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
K2 Principal Fund's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $17.1M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on K2 Principal Fund's 13F filing for Q4 2015, filed 12 Feb 2016.